ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
85 hedge funds and large institutions have $142M invested in Antares Pharma, Inc. in 2017 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
18% more capital invested
Capital invested by funds: $121M → $142M (+$21.2M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
85
Holding in Top 10
2
Calls
$372K
Puts
$130K
Top Buyers
| 1 | +$8.22M | |
| 2 | +$4.37M | |
| 3 | +$3.43M | |
| 4 |
Morgan Stanley
New York
|
+$1.71M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.64M |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$6.53M | |
| 3 | -$2.15M | |
| 4 |
KCM
Kingdon Capital Management
New York
|
-$620K |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$434K |